J. Dent, H. El-serag, M. Wallander, and S. Johansson, Epidemiology of gastro-oesophageal reflux disease: a systematic review, Gut, vol.54, issue.5, pp.710-717, 2005.
DOI : 10.1136/gut.2004.051821

H. Hampel, N. Abraham, and H. El-serag, Meta-Analysis: Obesity and the Risk for Gastroesophageal Reflux Disease and Its Complications, Annals of Internal Medicine, vol.143, issue.3, pp.199-211, 2005.
DOI : 10.7326/0003-4819-143-3-200508020-00006

J. Pandolfino, H. El-serag, Q. Zhang, N. Shah, S. Ghosh et al., Obesity: A Challenge to Esophagogastric Junction Integrity, Gastroenterology, vol.130, issue.3, pp.639-649, 2006.
DOI : 10.1053/j.gastro.2005.12.016

B. Jacobson, Body Mass Index and the Efficacy of Acid-Mediating Agents for GERD, Digestive Diseases and Sciences, vol.28, issue.9, pp.2313-2317, 2008.
DOI : 10.1007/s10620-008-0414-8

Y. Leykin, L. Miotto, and T. Pellis, Pharmacokinetic considerations in the obese, Best Practice & Research Clinical Anaesthesiology, vol.25, issue.1, pp.27-36, 2011.
DOI : 10.1016/j.bpa.2010.12.002

M. Hanley, D. Abernethy, and D. Greenblatt, Effect of Obesity on the Pharmacokinetics of Drugs in Humans, Clinical Pharmacokinetics, vol.16, issue.5 Pt 1, pp.71-87, 2010.
DOI : 10.2165/11318100-000000000-00000

G. Cheymol, Effects of Obesity on Pharmacokinetics, Clinical Pharmacokinetics, vol.26, issue.3, pp.215-231, 2000.
DOI : 10.2165/00003088-200039030-00004

S. Yasuda, Y. Horai, Y. Tomono, H. Nakai, C. Yamato et al., Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S-mephenytoin 4???-hydroxylation status, Clinical Pharmacology & Therapeutics, vol.52, issue.2, pp.143-154, 1995.
DOI : 10.1016/0009-9236(95)90192-2

B. Sheu, H. Cheng, W. Chang, W. Chen, and A. Kao, The Impact of Body Mass Index on the Application of On-Demand Therapy for Los Angeles Grades A and B Reflux Esophagitis, The American Journal of Gastroenterology, vol.102, issue.4, pp.2387-2394, 2007.
DOI : 10.1080/003655298750026697

B. Sheu, W. Chang, H. Cheng, A. Kao, and C. Lu, Body Mass Index Can Determine the Healing of Reflux Esophagitis With Los Angeles Grades C and D by Esomeprazole, The American Journal of Gastroenterology, vol.4, issue.Suppl 1, pp.1-6, 2008.
DOI : 10.1111/j.1572-0241.2008.01979.x

W. Chen, W. Chang, Y. Tsai, H. Cheng, C. Lu et al., Double-Dosed Pantoprazole Accelerates the Sustained Symptomatic Response in Overweight and Obese Patients With Reflux Esophagitis in Los Angeles Grades A and B, The American Journal of Gastroenterology, vol.39, issue.5, pp.1046-1052, 2010.
DOI : 10.1080/003655298750026697

F. Pace, B. Coudsy, B. Delemos, Y. Sun, J. Xiang et al., Does BMI affect the clinical efficacy of proton pump inhibitor therapy in GERD? The case for rabeprazole, European Journal of Gastroenterology & Hepatology, vol.23, issue.10, pp.845-851, 2011.
DOI : 10.1097/MEG.0b013e32834991b7

S. Bruleydesvarannes, E. Coron, and J. Galmiche, Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs?, Best Practice & Research Clinical Gastroenterology, vol.24, issue.6, pp.905-921, 2010.
DOI : 10.1016/j.bpg.2010.09.004

S. Bruley-des-varannes, PPI in gastroesophageal reflux disease, Balance of Usage PPI in GI Disease, pp.34-46

R. Fass, Alternative Therapeutic Approaches to Chronic Proton Pump Inhibitor Treatment, Clinical Gastroenterology and Hepatology, vol.10, issue.4, pp.338-345, 2012.
DOI : 10.1016/j.cgh.2011.12.020

S. Bruley-des-varannes, B. Coudsy, S. Waechter, B. Delemos, J. Xiang et al., On-demand proton pump inhibitory treatment in overweight/obese patients with gastro-oesophageal reflux disease: are there pharmacodynamic arguments for using higher dose? Digestion, pp.56-63, 2013.

S. Bruley-des-varannes, H. Gharib, V. Bicheler, R. Bost, B. Bonaz et al., Effect of low-dose rabeprazole and omeprazole on gastric acidity: results of a double blind, randomized, placebo-controlled, three-way crossover study in healthy subjects, Alimentary Pharmacology and Therapeutics, vol.52, issue.1, pp.899-907, 2004.
DOI : 10.1111/j.1572-0241.2002.05769.x

C. Pehl, I. Boccali, M. Hennig, and W. Schepp, pH probe positioning for 24-hour pH-metry by manometry or pH step-up, European Journal of Gastroenterology & Hepatology, vol.16, issue.4, pp.375-382, 2004.
DOI : 10.1097/00042737-200404000-00002

M. Can, G. Yagci, S. Cetiner, M. Gulsen, T. Yigit et al., Accurate positioning of the 24-hour pH monitoring catheter: Agreement between manometry and pH step-up method in two patient positions, World Journal of Gastroenterology, vol.13, issue.46, pp.6197-6202, 2007.
DOI : 10.3748/wjg.13.6197

P. Peghini, P. Katz, N. Bracy, and D. Castell, Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors, The American Journal of Gastroenterology, vol.89, issue.108, pp.763-767, 1998.
DOI : 10.1046/j.1365-2036.1996.33175000.x

M. Williams, J. Sercombe, M. Hamilton, and R. Pounder, A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects, Alimentary Pharmacology and Therapeutics, vol.109, issue.11, pp.1079-1089, 1998.
DOI : 10.1074/jbc.272.36.22438

J. Luo, C. Niu, X. Wang, Y. Zhu, and J. Gong, Effect of a single oral dose of rabeprazole on nocturnal acid breakthrough and nocturnal alkaline amplitude, World J Gastroenterol, vol.9, pp.2583-2586, 2003.

D. Pantoflickova, G. Dorta, M. Ravic, P. Jornod, and A. Blum, Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors, Alimentary Pharmacology and Therapeutics, vol.122, issue.12, pp.1507-1514, 2003.
DOI : 10.1046/j.1365-2036.2002.0160s1031.x

S. Warrington, K. Baisley, K. Dunn, M. Boyce, and A. Morocutti, Effects of single doses of rabeprazole 20??mg and esomeprazole 40??mg on 24-h intragastric pH in healthy subjects, European Journal of Clinical Pharmacology, vol.20, issue.Suppl 6, pp.685-689, 2006.
DOI : 10.1007/s00228-006-0148-5

P. Müller, M. Göksu, W. Fuchs, F. Schlüter, and B. Simon, Initial potency of lansoprazole and omeprazole tablets on pentagastrin-stimulated gastric acid secretion-a placebo-controlled study in healthy volunteers, Alimentary Pharmacology and Therapeutics, vol.25, issue.9, pp.1225-1229, 2000.
DOI : 10.1046/j.1365-2036.1997.157332000.x

M. Robinson and J. Horn, Clinical Pharmacology of Proton Pump Inhibitors, Drugs, vol.14, issue.24, pp.2739-2754, 2003.
DOI : 10.2165/00003495-200363240-00004

M. Kotlyar and S. Carson, Effects of obesity on the cytochrome P450 enzyme system, Int J Clin Pharmacol Ther, vol.37, pp.8-19, 1999.

J. Horn, Review article: relationship between the metabolism and efficacy of proton pump inhibitors - focus on rabeprazole, Alimentary Pharmacology and Therapeutics, vol.13, issue.s6, pp.11-19, 2004.
DOI : 10.1046/j.1365-2036.1999.00022.x